SERUM ANTIBODIES IN EPILEPSY

SERUM ANTIBODIES IN EPILEPSY

Čájet eará veršuvnnaid (1)

Bibliográfalaš dieđut
Váldodahkkit:	Brenner, T, Hart, Y, Howell, S, Palace, J, Sills, G, Brodie, M, Liguori, R, Vincent, A, Lang, B
Materiálatiipa:	Conference item
Almmustuhtton:	2009

Geahča maid

SERUM ANTIBODIES IN EPILEPSY
Dahkki: Brenner, T, et al.
Almmustuhtton: (2009)

Prevalence of neurologic autoantibodies in cohorts of patients with new and established epilepsy.
Dahkki: Brenner, T, et al.
Almmustuhtton: (2013)

Serum antibodies in patients with epilepsy
Dahkki: Lang, B, et al.
Almmustuhtton: (2005)

Serum antibodies in epilepsy and seizure-associated disorders.
Dahkki: McKnight, K, et al.
Almmustuhtton: (2005)

SERUM AUTOANTIBODIES TO GLUTAMIC ACID DECARBOXYLASE ARE ASSOCIATED WITH REDUCED CORTICAL GABA LEVELS IN PATIENTS WITH EPILEPSY
Dahkki: Stagg, C, et al.
Almmustuhtton: (2009)

Autoantibodies as a cause of epilepsy
Dahkki: Wroe, S, et al.
Almmustuhtton: (2003)

Epilepsy: an autoimmune disease?
Dahkki: Palace, J, et al.
Almmustuhtton: (2000)

LATE ADULT ONSET TEMPORAL LOBE EPILEPSY WITH ANTIBODIES TO VOLTAGE GATED POTASSIUM CHANNELS
Dahkki: Matthews, L, et al.
Almmustuhtton: (2009)

EPILEPSY AND THE IMMUNE SYSTEM " ... IS THERE ANTIBODY THERE? ... ''
Dahkki: Wright, S, et al.
Almmustuhtton: (2012)

Antibodies to voltage-gated potassium and calcium channels in epilepsy.
Dahkki: Majoie, H, et al.
Almmustuhtton: (2006)

INVESTIGATION OF AUTO-ANTIBODIES IN PATIENTS DIAGNOSED WITH FOCAL EPILEPSY
Dahkki: Ekizoglu, E, et al.
Almmustuhtton: (2013)

Antibodies to neuronal targets in neurological and psychiatric diseases.
Dahkki: Vincent, A, et al.
Almmustuhtton: (2003)

Antibodies to voltage gated potassium channels in encephalitis
Dahkki: Palace, J, et al.
Almmustuhtton: (2002)

Autoantibodies in epilepsy
Dahkki: Lang, B, et al.
Almmustuhtton: (2007)

Are antibodies to ion channels and other neural antigens present in adults with coexistent epilepsy and Type 1 diabetes? A pilot study
Dahkki: Idris, I, et al.
Almmustuhtton: (2014)

Lack of antibodies to NMDAR or VGKC-complex in GAD and cardiolipin antibody-positive refractory epilepsy.
Dahkki: Liimatainen, S, et al.
Almmustuhtton: (2014)

Assessment of autoimmunity in the pathogenesis of epilepsies in young women with long-standing intractable drug-resistant epilepsy
Dahkki: Lekomtseva, Y, et al.
Almmustuhtton: (2008)

Isolated new onset 'atypical' optic neuritis in the NMO clinic: serum antibodies, prognoses and diagnoses at follow-up.
Dahkki: Piccolo, L, et al.
Almmustuhtton: (2016)

Absence of antibodies to glutamate receptor type 3 (GluR3) in Rasmussen encephalitis.
Dahkki: Watson, R, et al.
Almmustuhtton: (2004)

The development of a questionnaire to assess knowledge of epilepsy: 1--General knowledge of epilepsy.
Dahkki: Jarvie, S, et al.
Almmustuhtton: (1993)

Autoantibodies to glutamic acid decarboxylase in patients with epilepsy are associated with low cortical GABA levels.
Dahkki: Stagg, C, et al.
Almmustuhtton: (2010)

Autoantibodies in people with newly diagnosed focal epilepsy
Dahkki: McGinty, R, et al.
Almmustuhtton: (2017)

The clinical phenotype of non-paraneoplastic voltage gated potassium channel antibody (VGKC Ab) associated CNS disease
Dahkki: Seymour, A, et al.
Almmustuhtton: (2004)

Serum autoantibodies against intracellular antigens in multiple sclerosis
Dahkki: Lily, O, et al.
Almmustuhtton: (2002)

Incidence of serum anti-P/O-type and anti-N-type calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome.
Dahkki: Motomura, M, et al.
Almmustuhtton: (1997)

Towards defining antigenic targets for antibodies in multiple sclerosis
Dahkki: Littleton, E, et al.
Almmustuhtton: (2006)

NMDAR Antibodies and New-Onset Epilepsy
Dahkki: J Gordon Millichap
Almmustuhtton: (2009-05-01)

VGKC antibodies in pediatric encephalitis presenting with status epilepticus.
Dahkki: Suleiman, J, et al.
Almmustuhtton: (2011)

Antibody to aquaporin-4: serum levels correlate with clinical disease activity
Dahkki: Jarius, S, et al.
Almmustuhtton: (2008)

Serum autoantibodies to oligodendrocyte and neuronal cell surface antigens in multiple sclerosis patients
Dahkki: Lily, O, et al.
Almmustuhtton: (2002)

IgG and complement deposition and neuronal loss in cats and humans with epilepsy and voltage-gated potassium channel complex antibodies.
Dahkki: Klang, A, et al.
Almmustuhtton: (2014)

Neuronal antibodies in pediatric epilepsy: Clinical features and long-term outcomes of a historical cohort not treated with immunotherapy.
Dahkki: Wright, S, et al.
Almmustuhtton: (2016)

Glycine receptor antibodies in 2 cases of new, adult-onset epilepsy.
Dahkki: Zuliani, L, et al.
Almmustuhtton: (2014)

Serum autoantibodies to cell surface determinants in multiple sclerosis: a flow cytometric study.
Dahkki: Lily, O, et al.
Almmustuhtton: (2004)

Immunocapture and identification of cell membrane protein antigenic targets of serum autoantibodies.
Dahkki: Littleton, E, et al.
Almmustuhtton: (2009)

Glycine receptor antibodies in a boy with focal epilepsy and episodic behavioral disorder
Dahkki: Wuerfel, E, et al.
Almmustuhtton: (2014)

Glycine receptor antibodies in a boy with focal epilepsy and episodic behavioral disorder.
Dahkki: Wuerfel, E, et al.
Almmustuhtton: (2014)

Fetal arthrogryposis and maternal serum antibodies.
Dahkki: Dalton, P, et al.
Almmustuhtton: (2006)

Glutamate receptor δ2 serum antibodies in pediatric opsoclonus myoclonus ataxia syndrome
Dahkki: Berridge, G, et al.
Almmustuhtton: (2018)

A radioimmuno-precipitation assay for antibodies to botulinum A.
Dahkki: Palace, J, et al.
Almmustuhtton: (1998)